Acceder Registro /

ALBERTO BAROJA MAZO

Buscador

Lucas-Ruiz F, Penin-Franch A, Pons JA, Ramirez P, Pelegrin P, Cuevas S, Baroja-Mazo A. Emerging Role of NLRP3 Inflammasome and Pyroptosis in Liver Transplantation. Int J Mol Sci. 2022 Nov 19;23(22):14396. doi: 10.3390/ijms232214396. PubMed PMID: 36430874; PubMed Central PMCID: PMC9698208.
AÑO: 2022; IF: 5.6
Hurtado-Navarro L, Baroja-Mazo A, Martinez-Banaclocha H, Pelegrin P. Assessment of ASC Oligomerization by Flow Cytometry. Methods Mol Biol. 2022;2459:1-9. doi: 10.1007/978-1-0716-2144-8_1. PubMed PMID: 35212949.
AÑO: 2022
Hurtado-Navarro L, Baroja-Mazo A, Pelegrin P. Characterization of P2X7 Receptors in Human Blood Cells. Methods Mol Biol. 2022;2510:279-290. doi: 10.1007/978-1-0716-2384-8_15. PubMed PMID: 35776331.
AÑO: 2022
Hurtado-Navarro L, Angosto-Bazarra D, Pelegrin P, Baroja-Mazo A, Cuevas S. NLRP3 Inflammasome and Pyroptosis in Liver Pathophysiology: The Emerging Relevance of Nrf2 Inducers. Antioxidants (Basel). 2022 Apr 28;11(5):870. doi: 10.3390/antiox11050870. PubMed PMID: 35624734; PubMed Central PMCID: PMC9137763.
AÑO: 2022; IF: 7.675
Garcia-Villalba J, Hurtado-Navarro L, Penin-Franch A, Molina-Lopez C, Martinez-Alarcon L, Angosto-Bazarra D, Baroja-Mazo A, Pelegrin P. Soluble P2X7 Receptor Is Elevated in the Plasma of COVID-19 Patients and Correlates With Disease Severity. Front Immunol. 2022 May 18;13:894470. doi: 10.3389/fimmu.2022.894470. eCollection 2022. PubMed PMID: 35663992; PubMed Central PMCID: PMC9161710.
AÑO: 2022; IF: 7.3

Instituto de Investigación Sanitaria Acreditado

ISCII

Fondo Social Europeo "El FSE Invierte en tu futuro"

Fondo Social Europeo

Sello de Calidad Europeo "HR Excellence in Research"

HRS4R